Genes that produce anti-cancer chemicals in soft coral identified opening route to production
From fluorescent jellyfish proteins to drug-inspiring cone snail toxins, marine animals are a biomedical treasure trove. Soft corals and their relatives, collectively known as octocorals, possess a vast library of particularly promising compounds, diterpenes, currently under investigation as potential drugs. Yet, with little understanding of how they are produced, synthesising them in the laboratory has proved difficult, hindering progress. In a recent breakthrough, researchers identified a cluster of genes involved in the synthesis of eleutherobin, a coral diterpene with potent anti-cancer activity, in the genome of the soft coral Erythropodium caribaeorum (pictured). Unlike in many marine animals, eleutherobin is not produced by a bacterial symbiont, a microbial partner living within the coral, but by the coral itself, and similar genes exist in other octocoral genomes, suggesting that diterpene production is an ancient adaptation. Elucidating this genetic pathway provides key tools for making coral diterpenes, boosting their potential for drug development.
BPoD stands for Biomedical Picture of the Day. Managed by the MRC Laboratory of Medical Sciences until Jul 2023, it is now run independently by a dedicated team of scientists and writers. The website aims to engage everyone, young and old, in the wonders of biology, and its influence on medicine. The ever-growing archive of more than 4000 research images documents over a decade of progress. Explore the collection and see what you discover. Images are kindly provided for inclusion on this website through the generosity of scientists across the globe.
BPoD is also available in Catalan at www.bpod.cat with translations by the University of Valencia.